Tazverik® (tazemetostat)
for Lymphoma

Tazverik (tazemetostat) is used to treat advanced epithelioid sarcoma in patients 16 and older when the cancer is metastatic or cannot be removed with surgery. It also treats adults with follicular lymphoma that has returned or not responded to treatment, either with an abnormal EZH2 gene after two prior therapies or when no other options are available. Tazverik works by slowing or stopping the growth of cancer cells.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Lymphoma